These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23853103)

  • 1. Proposal for generating new beta cells in a muted immune environment for type 1 diabetes.
    Levetan C; Pozzilli P; Jovanovic L; Schatz D
    Diabetes Metab Res Rev; 2013 Nov; 29(8):604-6. PubMed ID: 23853103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice.
    Suarez-Pinzon WL; Rabinovitch A
    Cell Transplant; 2011; 20(9):1343-9. PubMed ID: 21396168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors: impact on glucose metabolism.
    Boj-Carceller D
    Endocrine; 2013 Feb; 43(1):22-32. PubMed ID: 22886351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
    Cabrera SM; Colvin SC; Tersey SA; Maier B; Nadler JL; Mirmira RG
    Clin Exp Immunol; 2013 Jun; 172(3):375-82. PubMed ID: 23600825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice.
    Suarez-Pinzon WL; Lakey JR; Rabinovitch A
    Cell Transplant; 2008; 17(6):631-40. PubMed ID: 18819251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination immunotherapies for type 1 diabetes mellitus.
    Pozzilli P; Maddaloni E; Buzzetti R
    Nat Rev Endocrinol; 2015 May; 11(5):289-97. PubMed ID: 25688000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model.
    Nti BK; Markman JL; Bertera S; Styche AJ; Lakomy RJ; Subbotin VM; Trucco M; Zorina TD
    Cell Mol Immunol; 2012 Nov; 9(6):455-63. PubMed ID: 23042535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
    Gagliani N; Jofra T; Posgai AL; Atkinson MA; Battaglia M
    PLoS One; 2015; 10(11):e0142318. PubMed ID: 26580221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reg3g overexpression promotes β cell regeneration and induces immune tolerance in nonobese-diabetic mouse model.
    Xia F; Cao H; Du J; Liu X; Liu Y; Xiang M
    J Leukoc Biol; 2016 Jun; 99(6):1131-40. PubMed ID: 26667474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes.
    Astorri E; Guglielmi C; Bombardieri M; Alessandri C; Buzzetti R; Maggi D; Valesini G; Pitzalis C; Pozzilli P
    Horm Metab Res; 2010 Dec; 42(13):955-60. PubMed ID: 20972946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.
    Waldron-Lynch F; Herold KC
    Nat Rev Drug Discov; 2011 Jun; 10(6):439-52. PubMed ID: 21629294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass.
    Suarez-Pinzon WL; Lakey JR; Brand SJ; Rabinovitch A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3401-9. PubMed ID: 15769977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group.
    Skyler JS; Rabinovitch A
    J Diabetes Complications; 1992; 6(2):77-88. PubMed ID: 1611143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andrographolide promotes pancreatic duct cells differentiation into insulin-producing cells by targeting PDX-1.
    Zhang S; Huang F; Tian W; Lai J; Qian L; Hong W; Chen H; Li LC
    Biochem Pharmacol; 2020 Apr; 174():113785. PubMed ID: 31887289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
    Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
    Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.
    Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Yin Z; Li H; Zhang Y; Diao Y; Li Y; Chen Y; Sun X; Fisk MB; Skidgel R; Holterman M; Prabhakar B; Mazzone T
    BMC Med; 2012 Jan; 10():3. PubMed ID: 22233865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine therapies for the prevention of type 1 diabetes mellitus.
    Petrovsky N; Silva D; Schatz DA
    Paediatr Drugs; 2003; 5(9):575-82. PubMed ID: 12956615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reprogramming pancreatic cells to β cells].
    Vieira A; Druelle N; Courtney M; Avolio F; Ben-Othman N; Pfeifer A; Gjernes E; Faurite B; Collombat P
    Med Sci (Paris); 2013; 29(8-9):749-55. PubMed ID: 24005630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.